1126 related items for PubMed ID: 29745742
1. Delayed intravenous immunoglobulin treatment increased the risk of coronary artery lesions in children with Kawasaki disease at different status.
Qiu H, He Y, Rong X, Ren Y, Pan L, Chu M, Wu R, Shi H.
Postgrad Med; 2018 May; 130(4):442-447. PubMed ID: 29745742
[Abstract] [Full Text] [Related]
2. Predictors for intravenous immunoglobulin resistance and coronary artery lesions in Kawasaki disease.
Xie T, Wang Y, Fu S, Wang W, Xie C, Zhang Y, Gong F.
Pediatr Rheumatol Online J; 2017 Mar 21; 15(1):17. PubMed ID: 28320400
[Abstract] [Full Text] [Related]
3. Infliximab Plus Intravenous Immunoglobulin (IVIG) Versus IVIG Alone as Initial Therapy in Children With Kawasaki Disease Presenting With Coronary Artery Lesions: Is Dual Therapy More Effective?
Jone PN, Anderson MS, Mulvahill MJ, Heizer H, Glodé MP, Dominguez SR.
Pediatr Infect Dis J; 2018 Oct 21; 37(10):976-980. PubMed ID: 29461447
[Abstract] [Full Text] [Related]
4. Importance of C-reactive protein level in predicting non-response to additional intravenous immunoglobulin treatment in children with Kawasaki disease: a retrospective study.
Iwashima S, Kimura M, Ishikawa T, Ohzeki T.
Clin Drug Investig; 2011 Oct 21; 31(3):191-9. PubMed ID: 21456105
[Abstract] [Full Text] [Related]
5. Predictive value of monocyte to HDL-C ratio for coronary artery lesions and intravenous immunoglobulin resistance in Kawasaki disease.
Wang JR, Zhao HZ, Chang LJ, Xu X, Gao Y, Li M, Kong QY, Wang MM, Zhao CF.
Eur J Pediatr; 2023 Oct 21; 182(10):4399-4406. PubMed ID: 37480545
[Abstract] [Full Text] [Related]
6. A Retrospective Cohort Study of Intravenous Immunoglobulin Therapy in the Acute Phase of Kawasaki Disease: The Earlier, the Better?
Li W, He X, Zhang L, Wang Z, Wang Y, Lin H, Yuan J, Xie X, Qin Y, Huang P.
Cardiovasc Ther; 2021 Oct 21; 2021():6660407. PubMed ID: 34239607
[Abstract] [Full Text] [Related]
7. Timing of intravenous immunoglobulin treatment and risk of coronary artery abnormalities in children with Kawasaki disease.
Bal AK, Prasad D, Umali Pamintuan MA, Mammen-Prasad E, Petrova A.
Pediatr Neonatol; 2014 Oct 21; 55(5):387-92. PubMed ID: 24636168
[Abstract] [Full Text] [Related]
8. Facial nerve palsy may indicate coronary artery lesions in Kawasaki disease.
Chen J, Liu P, Hu W, Xu Y, Deng J.
Clin Rheumatol; 2021 Oct 21; 40(10):4191-4197. PubMed ID: 34059986
[Abstract] [Full Text] [Related]
9. Clinical relevance of the risk factors for coronary artery lesions in Kawasaki disease.
Weng KP, Hsieh KS, Huang SH, Ou SF, Ma CY, Ho TY, Lai CR, Ger LP.
Kaohsiung J Med Sci; 2012 Jan 21; 28(1):23-9. PubMed ID: 22226058
[Abstract] [Full Text] [Related]
10. A comparison of serum IL6 and CRP levels with respect to coronary changes and treatment response in Kawasaki disease patients: a prospective study.
Nandi A, Pal P, Basu S.
Rheumatol Int; 2019 Oct 21; 39(10):1797-1801. PubMed ID: 31302740
[Abstract] [Full Text] [Related]
11. Corticosteroid Therapy Might be Associated with the Development of Coronary Aneurysm in Children with Kawasaki Disease.
Zhao CN, Du ZD, Gao LL.
Chin Med J (Engl); 2016 Apr 20; 129(8):922-8. PubMed ID: 27064036
[Abstract] [Full Text] [Related]
12. The role of serum lipid in predicting coronary artery lesions and intravenous immunoglobulin resistance in Kawasaki disease: a cohort study.
Zhang H, Cai J, Zhang R, Shuai S, Tang M, Ju R, Hu Y, Zuo T, Yang Y.
J Int Med Res; 2024 May 20; 52(5):3000605241252115. PubMed ID: 38713460
[Abstract] [Full Text] [Related]
13. Kawasaki disease in Turkish children: a single center experience with emphasis on intravenous immunoglobulin resistance and giant coronary aneurysms.
Yılmazer MM, Özdemir R, Meşe T, Küçük M, Öner T, Devrim İ, Bayram N, Güven B, Tavlı V.
Turk J Pediatr; 2019 May 20; 61(5):648-656. PubMed ID: 32104995
[Abstract] [Full Text] [Related]
14. Evaluation of intravenous immunoglobulin resistance and coronary artery lesions in relation to Th1/Th2 cytokine profiles in patients with Kawasaki disease.
Wang Y, Wang W, Gong F, Fu S, Zhang Q, Hu J, Qi Y, Xie C, Zhang Y.
Arthritis Rheum; 2013 Mar 20; 65(3):805-14. PubMed ID: 23440694
[Abstract] [Full Text] [Related]
15. Heart Rate, Responsiveness to Intravenous Immunoglobulin, and Coronary Artery Aneurysms in Kawasaki Disease.
Miyakoshi C, Yamamoto Y, Yamakawa M, Fukuhara S.
J Pediatr; 2018 Sep 20; 200():160-165.e5. PubMed ID: 29793867
[Abstract] [Full Text] [Related]
16. Difference in Risk Factors for Subtypes of Acute Cardiac Lesions Resulting from Kawasaki Disease.
Yamashita M, Ae R, Yashiro M, Aoyama Y, Sano T, Makino N, Nakamura Y.
Pediatr Cardiol; 2017 Feb 20; 38(2):375-380. PubMed ID: 27878631
[Abstract] [Full Text] [Related]
17. Association between maternal age and outcomes in Kawasaki disease patients.
Huang WD, Lin YT, Tsai ZY, Chang LS, Liu SF, Lin YJ, Kuo HC.
Pediatr Rheumatol Online J; 2019 Jul 19; 17(1):46. PubMed ID: 31324255
[Abstract] [Full Text] [Related]
18. Clinical indicators combined with S100A12/TLR2 signaling molecules to establish a new scoring model for coronary artery lesions in Kawasaki disease.
Wu Y, Wang S, Zhou Y, Yang Y, Li S, Yin W, Ding Y.
PLoS One; 2023 Jul 19; 18(10):e0292653. PubMed ID: 37824465
[Abstract] [Full Text] [Related]
19. Serum IL-41 might be a biomarker for IVIG resistance and coronary artery lesions in Kawasaki disease.
Duan Y, Li H, Luo D, Jiang J, Liu B, Li G.
Int Immunopharmacol; 2023 Sep 19; 122():110600. PubMed ID: 37423157
[Abstract] [Full Text] [Related]
20. Development of coronary artery lesions in indolent Kawasaki disease following initial spontaneous defervescence: a retrospective cohort study.
Takahashi T, Sakakibara H, Morikawa Y, Miura M.
Pediatr Rheumatol Online J; 2015 Nov 04; 13(1):44. PubMed ID: 26530040
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
